Edwards Lifesciences Corp (EW) concluded trading on Thursday at a closing price of $93.34, with 3.31 million shares of worth about $308.56 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 22.36% during that period and on June 27, 2024 the price saw a gain of about 1.94%. Currently the company’s common shares owned by public are about 601.10M shares, out of which, 592.96M shares are available for trading.
Stock saw a price change of 5.07% in past 5 days and over the past one month there was a price change of 7.24%. Year-to-date (YTD), EW shares are showing a performance of 22.41% which increased to 3.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $60.57 but also hit the highest price of $96.12 during that period. The average intraday trading volume for Edwards Lifesciences Corp shares is 2.77 million. The stock is currently trading 5.84% above its 20-day simple moving average (SMA20), while that difference is up 6.55% for SMA50 and it goes to 16.85% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Edwards Lifesciences Corp (NYSE: EW) currently have 601.10M outstanding shares and institutions hold larger chunk of about 83.56% of that.
The stock has a current market capitalization of $56.25B and its 3Y-monthly beta is at 1.11. PE ratio of stock for trailing 12 months is 40.12, while it has posted earnings per share of $2.33 in the same period. Its PEG reads 3.74 and has Quick Ratio of 2.67 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EW, volatility over the week remained 2.04% while standing at 2.12% over the month.
Stock’s fiscal year EPS is expected to rise by 10.50% while it is estimated to increase by 11.98% in next year. EPS is likely to shrink at an annualized rate of 10.72% for next 5-years, compared to annual growth of 15.35% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on May 30, 2024 offering a Buy rating for the stock and assigned a target price of $107 to it. Coverage by Citigroup stated Edwards Lifesciences Corp (EW) stock as a Buy in their note to investors on May 22, 2024, suggesting a price target of $105 for the stock. Stock get an Overweight rating from Wells Fargo on February 02, 2024.
